Reversible severe fatty liver induced by capecitabine: A case report.

about

Reversible severe fatty liver induced by capecitabine: A case report.

Item

http://www.wikidata.org/entity/Q47139930

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Reversible severe fatty liver induced by capecitabine: A case report.

@en

Reversible severe fatty liver induced by capecitabine: A case report.

@nl

type

Item

label

Reversible severe fatty liver induced by capecitabine: A case report.

@en

Reversible severe fatty liver induced by capecitabine: A case report.

@nl

prefLabel

Reversible severe fatty liver induced by capecitabine: A case report.

@en

Reversible severe fatty liver induced by capecitabine: A case report.

@nl

P1476

Reversible severe fatty liver induced by capecitabine: A case report.

@en

P2093

Chang Shi

http://www.w3.org/2001/XMLSchema#string

Qiancheng He

http://www.w3.org/2001/XMLSchema#string

Suxia Li

http://www.w3.org/2001/XMLSchema#string

Xiaolei Yang

http://www.w3.org/2001/XMLSchema#string

Yiyan Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Intragenic deletions and a deep intronic mutation affecting pre-mRNA splicing in the dihydropyrimidine dehydrogenase gene as novel mechanisms causing 5-fluorouracil toxicity.

Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease

Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review.

Capecitabine: an overview of the side effects and their management.

Lethal cardiotoxicity, steatohepatitis, chronic pancreatitis, and acute enteritis induced by capecitabine and oxaliplatin in a 36-year-old woman.

Unanticipated toxicity to capecitabine.

Breast cancer, DPYD mutations and capecitabine-related ileitis: description of two cases and a review of the literature.

Safety of capecitabine: a review.

Treatment decisions after diagnosis of metastatic colorectal cancer.

First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin.

P304

e8547

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1097/MD.0000000000008547

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29145260

http://www.w3.org/2001/XMLSchema#string

P932

5704805

http://www.w3.org/2001/XMLSchema#string